Joint laxity, familial

disease
On this page

Also known as EDS 11 (formerly)EDS XIEDS11Ehlers-Danlos syndrome type 11, formerlyEhlers-Danlos syndrome, type 11 (formerly)familial joint instability syndromefamilial joint laxityJoint instability syndrome

Summary

Joint laxity, familial (MONDO:0007842) is a disease and 1 clinical trial. A subtype of Ehlers-Danlos syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide)
  • Phenotypes (HPO): 8
  • Clinical trials: 1

Clinical features

Signs & symptoms

Clinical features (HPO)

8 HPO clinical features (Orphanet curated; top 8 by frequency):

HPO IDTermFrequency
HP:0001382Joint hypermobilityVery frequent (80-99%)
HP:0001374Congenital hip dislocationVery frequent (80-99%)
HP:0002999Patellar dislocationVery frequent (80-99%)
HP:0002815Abnormality of the kneeFrequent (30-79%)
HP:0000023Inguinal herniaOccasional (5-29%)
HP:0002823Abnormality of femur morphologyOccasional (5-29%)
HP:0003834Shoulder dislocationOccasional (5-29%)
HP:0009811Abnormality of the elbowOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namejoint laxity, familial
Mondo IDMONDO:0007842
MeSHC535884
OMIM147900
Orphanet2295
SNOMED CT71322004
UMLSC0268349
MedGen120629
GARD0003054
Is cancer (heuristic)no

Also known as: EDS 11 (formerly) · EDS XI · EDS11 · Ehlers-Danlos syndrome type 11, formerly · Ehlers-Danlos syndrome, type 11 (formerly) · familial joint instability syndrome · familial joint laxity · Joint instability syndrome · joint laxity, familial

Disease family

This is a subtype of Ehlers-Danlos syndrome. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › syndromic diseaseEhlers-Danlos syndromejoint laxity, familial

Related subtypes (24): Ehlers-Danlos syndrome, classic type, Ehlers-Danlos syndrome, hypermobility type, Ehlers-Danlos syndrome, arthrochalasia type, Ehlers-Danlos syndrome, spondylodysplastic type, Ehlers-Danlos syndrome, periodontitis type, Ehlers-Danlos syndrome, autosomal dominant, type unspecified, Ehlers-Danlos syndrome, fibronectinemic type, Ehlers-Danlos syndrome, dermatosparaxis type, brittle cornea syndrome, X-linked Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome, Beasley-Cohen type, Ehlers-Danlos syndrome, kyphoscoliotic type, 2, Ehlers-Danlos syndrome, kyphoscoliotic type 1, Ehlers-Danlos syndrome, vascular-like type, Ehlers-Danlos/osteogenesis imperfecta syndrome, Ehlers-Danlos syndrome, vascular type, spondylodysplastic Ehlers-Danlos syndrome, Bethlem myopathy 2, Ehlers-Danlos syndrome, classic-like, 2, COL1A1-related Ehlers-Danlos syndrome, COL1A2-related Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, classic-like, 3

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified1

Top trials by phase / activity

NCTPhaseStatusTitle
NCT02725333Not specifiedCOMPLETEDDoes Shoulder Stabilizations Stabilize Shoulders?

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.